Drug delivery to brain by nanoparticles

Eksperimental'naya i Klinicheskaya Farmakologiya

Volumn 66, Issue 2, 2003, Pages 65-68

  Alyautdin, R N ^a   Kreuter, J ^b   Kharkevich, D A ^b  

^a I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; GLYCOPROTEIN P; LOW DENSITY LIPOPROTEIN RECEPTOR; PEPTIDE; POLY(BUTYLCYANOACRYLATE); POLYMER; POLYSORBATE 80; UNCLASSIFIED DRUG; DRUG CARRIER; ENBUCRILATE; MICROSPHERE; POLYSORBATE;

ARTICLE; BLOOD BRAIN BARRIER; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG RECEPTOR BINDING; ENDOCYTOSIS; ENDOTHELIUM CELL; HUMAN; NANOPARTICLE; ANIMAL; BRAIN DISEASE; NANOTECHNOLOGY; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN DISEASES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ENBUCRILATE; HUMANS; MICROSPHERES; NANOTECHNOLOGY; POLYSORBATES;

EID: 0142197365     PISSN: 08692092     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. R. N. Alyautdin, V. Petrov, D. A. Kharkevich, and J. Kreuter., Eur. J. Pharm. Biopharm., 41, 44-48, (1995).
2. R. N. Alyautdin, V. E. Petrov, K. Langer, A. Berthold, et al., Pharm. Res., 14, 325-328, (1997).
3. R. N. Alyautdin, E. B. Tezikov, P. Ramge, D. A. Kharkevich, et al., J. Microencapsulation, 15, 67-74, (1998).
4. R. N. Alyautdin, A. Reichel, R. Lobenberg, P. Ramge, et al., J. Drug Target., 9(3), 209-221, (2001).
5. L. Araujo, R. Lobenberg, J. Kreuter., J. Drug Target., 5, 373-385, (1999).
6. D. J. Begley, Prog. Brain Res., 91, 163-169, (1992).
7. E. Bigoa, E. Borato, A. Bruni, A. Leon, G. Toffano, Br. J. Pharmacol., 66, 167-174, (1979).
8. G. Borchard, K. L. Audus, F. Shi, J. Kreuter, Int. J. Pharm., 110, 29-35, (1994).
9. N. Bodor, E. Shek, T. Higuchi, Science, 190, 115-156, (1975).
10. C. Cordon-Cardo, J. P. O'Brien, D. Casals, L. Rittmann-Grauner, et al., Proc. Nati. Acad. Sci. USA, 86, 695-698, (1989).
11. P. Couvreur, L. Grislain, V. Lenaerts, and F. Brasseur, in: Polymeric Nanoparticles and Microspheres. Boca Raton, P. Guiot, P. Couvreur (eds.), FL: CRS Press (1986), pp. 27-93.
12. J. E. Cremer and M. P. Cereb., Blood Flow Metab., 3, 254-256, (1983).
13. B. Dehouck, C. Fenart, M.-P. Dehouck, and A. Pierce, J. Cell Biol., 138, 887-889, (1997).
14. R. Diepold, J. Kreuter, J. Himberg, R. Gurny, et al., Graefe's Arch. Clin. Exp. Ophthalmo., 1 227, 188-193, (1989).
15. R. Diepold, J. Kreuter, P. Guggenbiihl, and J. R. Robinson. Int. J. Pharm., 54, 149-153, (1989).
16. L. Grislain, P. Couvreur, V. Lenaerts, and M. Roland, Int. J. Pharm., 15, 335-345, (1983).
17. M. M. Gottesman and I. Pastan., Annu Rev Biochem., 62, 682-684, (1993).
18. J. D. Fenstermacher, P. Gross, N. Sposito, V. Acuff, et al., Ann. NY Acad. Sci., 529, 21-30, (1988).
19. E. Kalenikova, O. Dmitrieva, N. Korobov, et al., Vopr. Med. Khim., 34, 75-83, (1988).
20. J. Kreuter, Nanoparticles, in: J Swarbrick, JC Boylan (eds.), Encyclopedia of Pharmaceutical Technology, Vol 10, New York: Marcel Dekker, 1994, 165-190.
21. J. Kreuter, R. N. Alyautdin, D. A. Kharkevich, and A. A. Ivanov, Brain Res., 674, 171-174 (1995).
22. J. Kreuter, V. E. Petrov, D. A. Kharkevich, and R. N. Alyautdin., J. Controlled Rel., 49, 81-87, (1997).
23. J. Kreuter, R. N. Alyautdin, in: The Blood Brain Barrier and Drug Delivery to the CNS, ed. D. J. Begley, Marcel Dekker, 2000.
24. K. Langer, E. Mutschler, G. Lambrecht, D. Mayer H up., Int. J. Pharm., 158, 219-231, (1997).
25. V. Li, R. W. Wood, J. Kreuter, T. Harmia H up., J. Microencapsul., 3, 213-218, (1986).
26. M Luck, Plasmaproteinadsorption als moglicher Schliisselfaktor fur eine kontrollierte Arzneistoffapplikation mil partikularen Tragern. Ph. D. thesis, Freie Universitat Berlin (1997), pp. 130-154.
27. M. M. Nerurkar, P. S. Burto, and R. T. Borchardt, Pharm. Res., 13, 528-534, (1996).
28. E. A. Neuwelt, P. A. Barnett. In: E. A. Neuwelt, ed., Implications of the Blood-Brain Barrier and Its Manipulation, Vol 2, New York: Plenum Press, (1989).
29. A. Schinkel, E. Wagenaar, L. van Deemter, P. Borst., J. Clin. Invest., 97, 2517-2524, (1996).
30. V. Schroder and B. A. Sabel, Brain Res., 674, 121-124, (1996).
31. Z. A. Tokes, A. Kulcsar, and S. Peteri, J. A. Todd, Brain Res., 188, 282-286 (1980).
32. S. D. Troster, U. Miiller, and J. Kreuter., Int. J. Pharm., 61, 85-100 (1990).
33. S. D. Troster and J. Kreuter., J. Microencapsulation, 9, 19-28, (1992).
34. D. M. Woodcock, S. Jefferson, M. E. Linsenmeyer, P. J. Crowther, et al., Cancer Res., 50, 4199-4203 (1990).
35. D. M. Woodcock, M. E. Linsenmeyer, G. M. Chojnowski, A. B. Kriegler, Br. J. Cancer., 66, 62-68, (1992).
36. A. Zimmer, E. Mutschler, G. Lambrecht, D. Mayer, Pharm. Res., 11, 1435-1442, (1994).
37. A. K. Zimmer, H. Zerbe, J. Kreuter., J. Controlled Release, 32, 57-70, (1994).
38. A. K. Zimmer, P. Chetoni, M. F. Saettone, H. Zerbe, H .up., J. Controlled Release, 33, 31 -46, (1995).
39. A. K. Zimmer, P. Maincent, P. Thouvenot, J. Kreuter, Int. J. Pharm., 110, 211-222, (1994).
40. T. Zordan - Nudo, V. Ling, Z. Liv, E. Georges. Cancer. Res., 53, 5994-6000, (1993).